52 
Plant genetic engineering to fight ‘hidden hunger’
Scienmag
OCTOBER 16, 2020
Agriculture Agricultural Production/Economics Biology Biotechnology Food/Food Science Genetics Molecular Biology Nutrition/Nutrients Plant Sciences
Genetic Engineering Related Topics 
#news #biotech Restoring eyesight with genetically engineered stem cells
BioTech 365
DECEMBER 1, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Restoring eyesight with genetically engineered stem cells.Restoring eyesight with genetically engineered stem cells arlene.weintraub Mon, 11/30/2020 – 09:46 from FierceBiotech: Biotech [link].
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
FDA Approves Genetically Engineered Pigs for Food, Possible Medical Use
The Pharma Data
DECEMBER 14, 2020
FDA Approves Genetically Engineered Pigs for Food, Possible Medical Use. 14, 2020 — The first genetically engineered pigs for use as food or for potential future biomedical use — such as transplantation — in humans have been approved by the U.S.
#news #biotech Plant genetic engineering to fight hidden hunger
BioTech 365
OCTOBER 16, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Plant genetic engineering to fight hidden hunger.More than 2 billion people worldwide suffer from micronutrient malnutrition due to deficiencies in minerals and vitamins.
Genetic engineering without unwanted side effects helps fight parasites
Scienmag
DECEMBER 22, 2020
Around a third of the world’s population carries Toxoplasma gondii, a parasite that puts people with a weakened immune system at risk and can trigger malformations in the womb. The single-celled pathogen also leads to economic losses in agriculture, with toxoplasmosis increasing the risk of abortion among sheep, for example. The parasite has a complex […].
#news #biotech Genetic engineering without unwanted side effects helps fight parasites
BioTech 365
DECEMBER 23, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Genetic engineering without unwanted side effects helps fight parasites.Modified CRISPR-Cas9 gene editing scissors are enabling researchers at the University of Zurich to make alterations to the genetic … Continue reading → #news
Genetically engineered T cells could lead to therapies for autoimmune diseases
Scienmag
DECEMBER 3, 2020
A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments. Medicine & Health Biotechnology cancer Cell Biology Gene Therapy Genetics Immunology/Allergies/Asthma Medicine/Health
Boston Pharmaceuticals Licenses Potential NASH Treatment from Novartis
BioSpace
AUGUST 31, 2020
Boston Pharmaceuticals licensed the drug candidate BOS-580, an injectable, genetically engineered variant of human FGF21
Is China Using CRISPR to Create Super Soldiers?
BioSpace
DECEMBER 3, 2020
Has China discovered a super-soldier formula through the capabilities of genetic engineering? A U.S. government official claims this is exactly what is happening
Cataloging nature’s hidden arsenal: Viruses that infect bacteria
Scienmag
DECEMBER 9, 2020
And despite the numerous clever drugs and genetic engineering […]. Biology Bacteriology Genetics Microbiology Virology
#news #biotech Can a miniscule worm hold the secret to genetically reversing brain damage?
BioTech 365
FEBRUARY 5, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Can a miniscule worm hold the secret to genetically reversing brain damage? A team of Hebrew University researchers have successfully used genetic engineering as a first step to … Continue reading → #news
Molecule holds promise to reprogram white blood cells for better cancer treatment
Scienmag
DECEMBER 13, 2020
In this type of therapy, T cells, a type of white blood cell, are collected from a patient’s blood and subjected to genetic engineering to produce T cells carrying a synthetic molecule termed chimeric antigen receptor (CAR) […].
Biotech cotton key to eliminating devastating pest from US and Mexico
Scienmag
DECEMBER 21, 2020
A multifaceted strategy combining genetically engineered cotton with classical pest control tactics eradicated the pink bollworm from […]. For much of the past century, the invasive pink bollworm wreaked havoc in the southwestern United States and northern Mexico — inflicting tens of millions of dollars in damage annually to cotton on both sides of the border.
CIBMTR Completes Enrollment in Yescarta® Long-Term Post-Marketing Safety Study, 2 Years Ahead of Schedule
BioTech 365
SEPTEMBER 8, 2020
Synergy between biotech and classical control tactics rid US of invasive pest
Scienmag
DECEMBER 21, 2020
Credit: Agricultural Research Service-USDA.
Flipping light on-off turns bacteria into chemical factories
Scienmag
SEPTEMBER 8, 2020
Credit: Avalos Lab/Princeton University Researchers at Princeton University have created a new and improved way to more precisely control genetically engineered bacteria: by simply switching the lights on and off.
Rubius Therapeutics Presents Preclinical Data for RTX-321, a Red Cell Therapeutic™ Oncology Product Candidate for HPV-Positive Cancers, Demonstrating its Dual Mechanism of Action
BioTech 365
OCTOBER 28, 2020
Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an … Continue reading → GlobeNewswireRTX-321 Induces Antigen-Specific Stimulation Combined with Broad Stimulation of Innate and Adaptive Immune Responses CAMBRIDGE, Mass., 28, 2020 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc.
$3.9M project on self-deleting genes takes aim at mosquito-borne diseases
Scienmag
DECEMBER 28, 2020
Texas A&M AgriLife researchers’ work to aid mosquito control efforts To control mosquito populations and prevent them from transmitting diseases such as malaria, many researchers are pursuing strategies in mosquito genetic engineering. A new Texas A&M AgriLife Research project aims to enable temporary “test runs” of proposed genetic changes in mosquitoes, after which the changes […].
COVID-19 lung damage caused by persistence of ‘abnormal cells’
Scienmag
NOVEMBER 3, 2020
The study, published today in The Lancet’s eBioMedicine, by King’s College London in collaboration with University of Trieste and the International Centre for Genetic Engineering and Biology in Italy, shows the unique characteristics to the SARS-CoV-2 virus and may […]. Investigations of deceased COVID-19 patients have shed light on possible lung damage caused by the virus.
Golden meat: Engineering cow cells to produce beta carotene
Scienmag
OCTOBER 14, 2020
Scientists prove cell-cultured meat products can offer enhanced nutrition compared to conventionally produced meat A group of researchers at Tufts University have genetically engineered cow muscle cells to produce plant nutrients not natively found in beef cells.
Genetic Vaccine Development for Infectious Diseases Summit
Pharma Phorum
MARCH 2, 2021
A combination of urgent need, unprecedented investments, and advances in genetic engineering has allowed what was once mere speculation to become not only our reality, but our future. The post Genetic Vaccine Development for Infectious Diseases Summit appeared first on.
Taconic Biosciences Expands Immuno-oncology Animal Model PortfolioCritical Jh Syngeneic Tumor Model Host Now Available on a B6 Background
The Pharma Data
JANUARY 17, 2021
These models are engrafted with mouse tumors derived from the same strain background; this genetic similarity between tumor and host prevents the host from rejecting the tumor. Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services.
PlateletBio Names Dr. Steven Altschuler as Chairman of its Board of Directors
The Pharma Data
JANUARY 27, 2021
Its cell therapy platform produces “platelet-like cells” (PLCs) capable of performing vital biological functions and able to be genetically engineered into multiple allogeneic therapies. 28, 2021 12:30 UTC. WATERTOWN, Mass.–(
Johns Hopkins Researchers Identify CRISPR Dimmer
The Pharma Data
JANUARY 19, 2021
But altering the tracr-L with genetic engineering to make it function more like a guide RNA increased CRISPR-Cas9 cuts.
AI-designed serotonin tracker could help develop neurology drugs
Pharma Phorum
DECEMBER 24, 2020
Tian’s lab builds on the work of scientists in the lab of Dr Loren Looger, Howard Hughes Medical Institute Janelia Research Campus, Ashburn, Virginia, who used traditional genetic engineering techniques to convert the bacterial protein into a sensor of the neurotransmitter acetylcholine.
South African variant may cut response from Pfizer/BioNTech shot, study finds
Pharma Phorum
FEBRUARY 18, 2021
Researchers from the University of Texas Medical Branch based their findings on lab tests using SARS-CoV-2 coronaviruses that were genetically engineered to have the same mutations as those in the strain that is causing scientists so much concern.
2nd Macrophage-directed Therapies Summit
Pharma Phorum
AUGUST 19, 2020
billion acquisition of Forty Seven by Gilead is an example of the explosive excitement and investment into macrophage-directed therapies, utilizing CD47 checkpoint blockades, repolarization approaches and engineered macrophages, that we have witnessed in recent months.
Could Fluoride be the Solution to Antibiotic Resistance? A New Study Weighs In
The Pharma Data
JANUARY 4, 2021
The UC Santa Barbara research uses a method that addresses not only antibiotic overuse, but also the containment of genetically modified organisms (GMOs). “If
AstraZeneca-Oxford COVID-19 Vaccine Shows High Efficacy
XTalks
NOVEMBER 23, 2020
Developed by researchers at the University of Oxford, the COVID vaccine is an adenovirus vector-based vaccine derived from chimpanzees that contains a genetically engineered virus that causes the common cold in chimpanzees, along with the spike protein of the SARS-CoV-2 coronavirus.
NHS and Kite sign access deal for Kite’s cancer cell therapy Tecartus
Pharma Phorum
JANUARY 19, 2021
CAR-T therapies are made by harvesting a patient’s T-cells, genetically engineering them to target cancer cells and reintroducing them into the body. NHS patients in England will be among the first in the world to receive Gilead’s Tecartus cancer cell therapy for certain types of lymphoma, after the company’s specialist Kite unit struck a deal with NICE. .
In the precision medicine era, the line between products and services is blurred
Pharma Phorum
SEPTEMBER 4, 2020
The treatments are developed using cutting- edge technologies such as genomic sequencing and genetic engineering, helping to account for the individual variability in both patient and disease characteristics.
Elasmogen announces a panel of novel, potent, anti-COVID-19 therapeutic candidates identified through collaboration with U.S. research partners
The Pharma Data
JANUARY 24, 2021
At Elasmogen we have been able to capture, using the latest protein and genetic engineering techniques, the immune system of 10,000 shark equivalents in a test-tube.
Novartis’ Ilaris fails in late-stage COVID-19 trial
Pharma Phorum
NOVEMBER 6, 2020
Novartis is also working with Molecular Partners to develop therapies based on genetically engineered proteins known as DARPins. Novartis’ Ilaris (canakinumab) has failed to produce results in a phase 3 trial, which tested whether it could improve COVID-19 patients’ survival chances without need for mechanical ventilation.
Good Gut Bacteria Can Aid in Healing Intestines Damaged by IBD
XTalks
JULY 31, 2020
The study developed and researched microbe-controlled and genetically-engineered mice to understand the healing response in the intestine when receiving specific signals from bacteria.
Clinical Catch-Up: January 4-8 | BioSpace
The Pharma Data
JANUARY 10, 2021
ILP100 is a genetically engineered Lactobacillus that acts as a small bioreactor on site in the wound, continuously introducing a chemokine, CXCL12, into the wound tissue. The new year began with a fairly low level of clinical trial news. Here’s a look. COVID-19-Related.
Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 VaccineAdvance purchase agreement signed for NVX-CoV2373, Novavax’ adjuvanted protein vaccine candidate
The Pharma Data
DECEMBER 16, 2020
NVX-CoV2373 is a protein-based vaccine candidate engineered from the genetic sequence of SARS-CoV-2, the virus that causes COVID-19 disease. GAITHERSBURG, Md., 16, 2020 (GLOBE NEWSWIRE) — Novavax , Inc.
Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
The Pharma Data
NOVEMBER 9, 2020
NVX-CoV2373 is a vaccine candidate engineered from the genetic sequence of SARS-CoV-2, the virus that causes COVID-19 disease. GAITHERSBURG, Md., 09, 2020 (GLOBE NEWSWIRE) — Novavax, Inc.
Targovax announces formation of new Scientific Advisory Board
The Pharma Data
OCTOBER 27, 2020
Dr. Zamarin’s clinical and laboratory research are focused on characterization of biomarkers in patients undergoing immunotherapy and on development of novel immunotherapeutic strategies using immunomodulatory antibodies and genetically-engineered oncolytic viruses.
Novavax Announces COVID-19 Vaccine Clinical Development Progress
The Pharma Data
NOVEMBER 30, 2020
CoV2373 is a stable, prefusion protein antigen derived from the genetic sequence of the SARS-CoV-2 coronavirus spike (S) protein and adjuvanted with Novavax’ proprietary Matrix?M. GAITHERSBURG, Md., 30, 2020 (GLOBE NEWSWIRE) — Novavax, Inc.
COVID-19 Vaccines Currently Being Developed and What It All Mean for Us
Riverside Clinical Research
OCTOBER 29, 2020
There are also genetically engineered vaccines which use RNA and DNA to copy the S protein in hopes of. There is no question that humankind requires assistance…a heavy-hitter, a formidable opponent to help. combat COVID-19. An effective vaccine is exactly that shot in the arm we need to protect ourselves. against this deadly pandemic. So, that begs the question, “Where are we in the process of COVID-19. vaccine development?”.
Aridis Pharmaceuticals to Present at the ROTH Capital Partners 2020 MedTech Innovation Forum on a COVID-19 Panel
The Pharma Data
OCTOBER 26, 2020
These mAbs are already of human origin and functionally optimized for high potency by the donor’s immune system; hence, they technically do not require genetic engineering or further optimization to achieve full functionality. SAN JOSE, Calif. ,
Crescita Announces Licensing Agreement for Pliaglis; in China
The Pharma Data
NOVEMBER 4, 2020
Relying on independent research and development, the Company has formed gene recombination and fermentation engineering technology, and developed a number of core technologies, such as recombinant collagen, enzymatic and genetic engineering synthesis of bioactive peptides. . LAVAL, QC, Nov. 5, 2020 /PRNewswire/ – Crescita Therapeutics Inc.
Biopharma Leaders Unite To Stand With Science
The Pharma Data
SEPTEMBER 8, 2020
Novavax is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles in order to address urgent global health needs.
Let's personalize your content